Floatz logo

Ebv-Specific T Cells: B

Hodgkins Lymphoma

Baylor College of MedicineCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

140 Active assets in the Hodgkins Lymphoma cohort.

Asset / SponsorPhaseRating
Everolimus
OHSU Knight Cancer Institute
Phase 2BBB
Camustine
VIVUS LLC
Phase 2BBB
Carboplatin
St. Petersburg State Pavlov Medical University
Phase 2BBB
Methotrexate
Therapeutic Advances in Childhood Leukemia Consortium
Phase 3BBB
Cyclosporin A
City of Hope Medical Center
Phase 3BBB

View all 50 →

Same molecule, other indications

Ebv-Specific T Cells: B is also rated in:

Epstein-Barr virus-associated lymphoproliferative disorderActive
CCC
Indicative · Phase 2
52 / 100
View asset →
Epstein-Barr virus-related tumorDormant
CCC
Indicative · Phase 2
52 / 100
View asset →
lymphoproliferative syndromeActive
CC
Indicative · Phase 1
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →